Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14407238 | 0.85 | KMT2A (0.33) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL27765552 | 0.85 | MEN1 (0.46) | ALDH1A1TSHRKMT2AMEN1POLB | |
| SCHEMBL3137939 | 0.82 | ALDH1A1 (0.51) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL9459079 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL6359410 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL9459074 | 0.81 | ALDH1A1 (0.55) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL28743041 | 0.81 | ALDH1A1 (0.50) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL3932099 | 0.80 | ALDH1A1 (0.53) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL5584278 | 0.78 | ALDH1A1 (0.59) | ALDH1A1TSHRKMT2AMEN1HPGD | |
| SCHEMBL28262812 | 0.78 | ALDH1A1 (0.55) | ALDH1A1TSHRKMT2AMEN1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2043995-B1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | BAYER CROPSCIENCE AG (DE) | 2013-01-02 | — | — | EP | disclosed |
| EP-2043995-B1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | BAYER CROPSCIENCE AG (DE) | 2013-01-02 | — | — | EP | disclosed |
| US-8071824-B2 | Method for producing alkenylnitrobenzene derivatives unbranched in the 1′-position | BAYER CROPSCIENCE AG (DE) | 2011-12-06 | — | — | US | disclosed |
| US-8071824-B2 | Method for producing alkenylnitrobenzene derivatives unbranched in the 1′-position | BAYER CROPSCIENCE AG (DE) | 2011-12-06 | — | — | US | disclosed |
| US-8071824-B2 | Method for producing alkenylnitrobenzene derivatives unbranched in the 1′-position | BAYER CROPSCIENCE AG (DE) | 2011-12-06 | — | — | US | disclosed |
| US-20100076229-A1 | Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position | BAYER CROPSCIENCE AG (DE) | 2010-03-25 | — | — | US | disclosed |
| US-20100076229-A1 | Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position | BAYER CROPSCIENCE AG (DE) | 2010-03-25 | — | — | US | disclosed |
| US-20100076229-A1 | Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position | BAYER CROPSCIENCE AG (DE) | 2010-03-25 | — | — | US | disclosed |
| EP-2043995-A1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | Bayer CropScience AG (DE) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008006576-A1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | BAYER CROPSCIENCE AG (DE) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008006576-A1 | A METHOD FOR PRODUCING ALKENYL NITROBENZOL DERIVATIVES UNBRANCHED IN THE 1-POSITION | BAYER CROPSCIENCE AG (DE) | 2008-01-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076229-A1 | Method for Producing Alkenylnitrobenzene Derivatives Unbranched in the 1'-Position | CYP1B1, AKR7A2, CYP1A1 | ALDH1A1 329/4885TSHR 3365/4885KMT2A 1165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.